RITMIR024 - STEM CELL RESEARCH IN CARDIOLOGY
|
|
|
- Jeffry Willis
- 8 years ago
- Views:
Transcription
1 1. SCOPE AND METHODOLOGY 2. REPORT SYNOPSIS 2.1 General Definitions Myoblasts Pluripotent Cells Multipotent Cells Progenitor Cells Role of Stem Cells in Repairing the Heart Stem Cell Therapy Stem Cells in Cardiology Cell Based Myocardial Repair Cord Blood Stem Cells in Regenerative Medicine Cardiocytes 2.2 Segmentation of Stem Cells in Cardiology Exhibit 1. Segmentation of Global Stem Cells Market in Cardiology by Source and by Type Source Allogenic Autogenic Type Bone Marrow Stem Cells Embryonic Stem Cells 2.3 Stem Cells in Cardiology - Global Market Analysis Exhibit 2. Stem Cells in Cardiology - Global Market Historic, Estimations and Predictions ( ) in US$ Million Exhibit 3. Stem Cells in Cardiology List of Major Global Companies 3. MARKET DYNAMICS 3.1 Market Overview 3.2 Global Stem Cells Market Exhibit 4. Stem Cells - Global Market Historic, Estimations and Predictions ( ) by Geographic Region for North America, Europe, Asia-Pacific and Rest of World in US$ Million Exhibit 5. Stem Cells - Global Market Shares (2010, 2015 & 2020) by Geographic Regions by North America, Europe, i
2 Asia-Pacific and Rest of World 3.3 Global Market for Stem Cells in Cardiology Exhibit 6. Stem Cells in Cardiology - Global Market Historic, Estimations and Predictions ( ) by Geographic Regions for North America, Europe, Asia-Pacifc and Rest of World in US$ Million Exhibit 7. Stem Cells in Cardiology - Global Market Shares (2010, 2015 & 2020) by Geographic Regions for North America, Europe, Asia-Pacifc and Rest of World 3.3 (I) North American Market for Stem Cells in Cardiology Exhibit 8. List of Major North American Stem Cells in Cardiology Companies Exhibit 9. Prevalence of Cardiovascular Diseases 2005 in the US Exhibit 10. US Death Rates for Cardiovascular and Non-Cardiovascular Disease 3.3 (II) European Market for Stem Cells in Cardiology Exhibit 11. List of Major European Stem Cells in Cardiology Companies Exhibit 12. Cardiovascular Disease: Death Statistics in Europe Exhibit 13. Death Statistics by Cause in Europe 3.3 (III) Asia-Pacific Market for Stem Cells in Cardiology Exhibit 14. List of Major Asia-Pacific Stem Cells in Cardiology Companies Exhibit 15. Death Statistics for Cardiovascular Disease in Asia-Pacific 3.3 (IV) Rest of World Market for Stem Cells in Cardiology Exhibit 16. List of Major Rest of World Stem Cells in Cardiology Companies Exhibit 17. Death Statistics for Cardiovascular Disease in Rest of World 3.4 Analysis by Source Exhibit 18. Stem Cells Market in Cardiology by Source - Global Market Historic, Estimations and Predictions ( ) for Allogenic and Autogenic Stem Cell Transplantation in US$ Million Exhibit 19. Stem Cells Market in Cardiology by Source - Global Market Shares (2010, 2015 & 2020) by Source for Allogenic and Autogenic Stem Cells 3.5 Analysis by Type Exhibit 20. Stem Cells in Cardiology by Type - Global Market Historic, Estimations and Predictions ( ) for Bone Marrow Stem Cells, Embryonic Stem Cells and Other in US$ Million Exhibit 21. Stem Cells in Cardiology by Type - Global Market Shares (2010, 2015 & 2020) for Bone Marrow Stem Cell, Embryonic Stem Cell and Other 3.6 Market Trends Israel Leads in Stem Cell Based Research Treating Heart Diseases with Stem Cells ii
3 Cord Blood Stem Cells Based Therapies for Diseases of the Heart and Blood Vessels Cord Blood Stem Cell Therapies for Enhancing the Performance of Heart s Ventricles, and Repairing Arteries and Veins Effectiveness of Cord Blood Stem Cells for Treating Congenital Heart Problems Effectiveness of Cord Blood Stem Cells Based Therapies for Treating Peripheral Vascular Disease Outlook for Cord Blood Stem Cells Based Medical Therapies Inactivation of P66sch Gene Provides a Solution to Rapid Aging of Stem Cells in the Heart, and Higher Risk of Heart Failure, Caused by Diabetes Mesenchymal Stem Cells from Bone Marrow Prompts Angiogenesis and Bring in Changes in Diabetic Cardiomyopathy Endothelial Progenitor Cells for Vascular Repairs Treating Cardiovascular Diseases with Endothelial Progenitor Cells Transplanted Fetal Cardiomyocytes Effective as Pacemaker in the Heart Adult Bone Marrow Stem Cells Used for Reproducing Myocardium in Case of Ischemic Heart Disease Multipotent Meso-Angioblast Collected from Dorsal Aorta is Capable of Self-Renewal, and Transformation into Majority of Cells Forming Mesodermal Tissues 3.7 Company Profiles - Major Players in Stem Cells in Cardiology Market Aastrom Biosciences, Inc. (USA) Advanced Cell Technology, Inc. (USA) Aldagen, Inc. (USA) Athersys, Inc. (USA) Axordia Ltd. (UK) Baxter International (USA) Bioheart, Inc. (USA) More. 3.8 Major Product Innovations/Launches in Stem Cell Research - Cardiology GSK and HSCI in Research Collaboration for Stem Cells Gamida Cell and Biologics Delivery Systems in Collaboration Agreement PerkinElmer Establishes Stem Cell Research Center Geron Reports Positive Results for Embryonic Stem Cell Therapy for Heart Failure New Type of Stem Cells Discovered on Epicardium by Scientists iii
4 Aastrom Starts Phase II Clinical Trials Using Cells from Patient s Own Bone Marrow to Treat Chronic Heart Failure Angioblast Systems Gets FDA Approval for Phase 2 Trial Pluristem Therapeutics Qualified as a Good Manufacturing Practices (GMP) Site for the More Stem Cells in Cardiology Market Outlook 4. PRODUCT/TECHNOLOGY RESEARCH 4.1 Introduction Coronary Angiography Cardiovascular Diseases Major Common Causes of CHD Myocardial Infarction Symptoms of MI Risk Factors Possible Therapies to Treat MI Adult Stem Cells in Myocardial Infarction Mobilized Stem Cells in Treating Myocardial Infarction Congestive Heart Failure Left-Sided Failure Right-Sided Failure Myocardial Rupture Risk Factors Classification of Myocardial Rupture Symptoms of Myocardial Rupture Treatment of Myocardial Rupture Cardiomyopathy Systemic Disease Causing Cardiomyopathy Extrinsic Cardiomyopathy Ischemic Cardiomyopathy Symptoms of Ischemic Cardiomyopathy Cord Blood Cells to Treat Ischemia iv
5 Intrinsic Cardiomyopathy Dilated Cardiomyopathy or DCM Hypertrophic Cardiomyopathy Arrhythmogenic Right Ventricular Cardiomyopathy Restrictive Cardiomyopathy Non Compaction Cardiomyopathy Malignant Cardiomyopathy/Accelerated Cardiomyopathy Signs and Symptoms Treatment Coronary Heart Disease Symptoms of Angina Pectoris Kinds of Angina Stable Angina Unstable Angina Hypertensive Heart Disease Symptoms Valvular Heart Disease Types of Valvular Diseases Inflammatory Heart Disease Stem Cells - Cardiology Bone Marrow Stem Cells Mononuclear Bone Marrow (MNBM) Stem Cells Heart Muscle Regeneration with Bone Marrow Stem Cells Introduction Adult Stem Cells Haematopoietic Stem Cells Mesenchymal Stem Cells Endothelial Progenitor Cells Myoblast Cells Fetal Cardiomyocytes Stem Cell Delivery Autologous Stem Cells v
6 Autologous Skeletal Myoblasts Delivery of Autologous Myoblasts by Catheter Functional Assessment of Stem Cell Therapy Cardiac Stem Cells Biology of Stem Cells Sources of Stem cells Allogenic Stem Cell Transplantation Autologous Stem Cell Transplantation Exhibit 22. Stem Cells Market in Cardiology by Source - Global Market Historic, Estimations and Predictions ( ) for Allogenic and Autogenic Stem Cell Transplantation in US$ Million Exhibit 23. Stem Cells Market in Cardiology by Source - Global Market Shares (2010, 2015 & 2020) by Source for Allogenic and Autogenic Stem Cells Autologous Products and their Allogenic Counterparts - Manufacturing Risks, Product Development and Business Models Stem Cells as Therapeutics The Ideal Cell Types for Cardiac Stem Cell Therapy Embryonic Stem Cells Embryonic Stem Cells for Treating Cardiovascular Diseases Lineage Specific Differentiation of Embryonic Stem Cells Induction of Cardiogenesis in Embryonic Stem Cells- Via Down regulation of Notch1 Gene Signaling Transformation of Embryonic Stem Cells into Cardiomyocytes Cardiomyocytes from Human Embryonic Stem Cells Stem Cells in Mitochondrial Faults and Toxicology Cord Blood Stem Cells in Treating Heart Diseases Exhibit 24. Stem Cells in Cardiology by Type - Global Market Historic, Estimations and Predictions ( ) for Bone Marrow Stem Cells, Embryonic Stem Cells and Other in US$ Million Exhibit 25. Stem Cells in Cardiology - Global Market Shares (2010, 2015 & 2020) by Type for Bone Marrow Stem Cell, Embryonic Stem Cell and Other Adult Stem Cells in Treating Heart Diseases Introduction Adult Stem Cell Therapy Improves Cardiac Function and Blood Flow Mesenchymal Stem Cells in Treating Heart Disease vi
7 Transformation of Mesenchymal Stem Cells into Cardiovascular Tissue Cells Human Cord Blood Mesenchymal Stem Cells Bone Marrow-Derived Stem Cells (BMSC) Administered through Intra-myocardial Injection Clinical Studies with Selected Bone Marrow Stem Cells Other Research Studies Gene Based Stem Cell Therapy Catheter - Device for Cardiac Stem Cell Delivery Uses Catheter Implantation Techniques of Stem Cell Delivery Transvascular Method Transendocardial Approach Transepicardial Approach Stem Cell Mobilization to the Injured Myocardium Stem Cell Imaging Cell Tracking by Use of Noninvasive Imaging Direct Labeling of Cells by Making Use of Magnetic Resonance Agents The Drawbacks of Magnetic Labeling Direct Labeling of Cells Using Radionuclides Nanoparticle Labeling Reporter Genes for Cardiovascular Cell Imaging The Future Prospects of Stem Cell Imaging Imaging to Assess the Functional Effects of Cell therapy Myocardial Perfusion Cell Therapy Issues Inconsistencies Cardiac Stem Cell Therapy with Emphasis on Certain Issues Yet to be Resolved Clinical Issues Involved in Cardiac Cell-Repair Therapy Disadvantages of Stem Cell Therapy in Cardiovascular Diseases Stem Cell Research and Regulatory Issues - A Summary Cardiac Muscle Regeneration Concerns Regarding Cell Therapy vii
8 The Principles of Stem Cell Research, Legal and Other Social Issues The Science of Stem Cells Embryonic Stem Cell Research in the UK Regulations Regarding Research on Embryo and Embryonic Stem Cells in the UK European Regulations International Regulation of Stem Cell Research Related Issues in Stem Cell Research Embryonic Stem Cell Research and Related Issues Regulation of Product Development The EU Tissue Directive Tissue Traceability and Donor Confidentiality Achieving Patient Trust in Stem Cell Therapy Intellectual Property Rights Intellectual Property Rights in the United Kingdom Intellectual Property Rights in Europe Opportunity Costs, Resource Allocation and Equity Longevity, Immortality and Individual Identity 4.2 Stem Cell Research in Cardiology Research Briefs 5. CORPORATE DIRECTORY 6. PATENTS INFORMATION viii
STEM CELL FELLOWSHIP
Module I: The Basic Principles of Stem Cells 1. Basics of Stem Cells a. Understanding the development of embryonic stem cells i. Embryonic stem cells ii. Embryonic germ cells iii. Differentiated stem cell
5 Frequently Asked Questions About Adult Stem Cell Research
5 Frequently Asked Questions About Adult Stem Cell Research Stem cells are often referred to in the sociopolitical realm with some level of controversy and beyond that, some level of confusion. Many researchers
STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE
STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE What are Stem Cells? Stem cells are the basic building blocks of all the cells, tissues and organs in the human body. The role of the stem
[Indian Stem Cell Banking Market: Trends & Opportunities (2012-2017)]
![[Indian Stem Cell Banking Market: Trends & Opportunities (2012-2017)]](/thumbs/33/16594674.jpg "[Indian Stem Cell Banking Market: Trends & Opportunities (2012-2017)]")
[Indian Stem Cell Banking Market: Trends & Opportunities (2012-2017)] Executive Summary Stem Cells have a remarkable ability to develop in various body cells of a human. These occur in the earliest stages
It s not something you want to think about, but it s something you want to prepare for.
It s not something you want to think about, but it s something you want to prepare for. StemCyte cord blood banking offers your family a new lifesaving treatment alternative Why Bank Take the once-in-alifetime
San Diego Stem Cell Treatment Center Frequently Asked Questions
San Diego Stem Cell Treatment Center Frequently Asked Questions What is a Stem Cell? A stem cell is basically any cell that can replicate and differentiate. This means the cell can not only multiply, but
What are Stem Cells? How can they be used in medicine?
What are Stem Cells? How can they be used in medicine? What is a stem cell????... What is a stem cell????......a cell with the ability to differentiate into specialized cells and renew to become more stem
INTRODUCTION TO EECP THERAPY
INTRODUCTION TO EECP THERAPY is an FDA cleared, Medicare approved, non-invasive medical therapy for the treatment of stable and unstable angina, congestive heart failure, acute myocardial infarction, and
Specific Basic Standards for Osteopathic Fellowship Training in Cardiology
Specific Basic Standards for Osteopathic Fellowship Training in Cardiology American Osteopathic Association and American College of Osteopathic Internists BOT 07/2006 Rev. BOT 03/2009 Rev. BOT 07/2011
The Types of stem cells: Totipotent Pluripotent Multipotent
Stem Cells is the main material for building and regeneration of the body Stem cells are not differentiated and can transform to any cell of organism Stem cells are capable of indefinite renewal through
4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.
WMDA Policy Statement on the Utility of Autologous or Family Cord Blood Unit Storage The WMDA Board adopted this policy on 25 th of May 2006. Policy updated _April 2011 The Cord Blood Working Group and
Stem Cell Research: Adult or Somatic Stem Cells
Chiang 1 Stem Cell Research: Adult or Somatic Stem Cells Abstract Kelly Chiang Cluster 7 Dr. LeFebvre 07/26/10 Over the past few decades, stem cells have been a controversial topic in the scientific field.
5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.
WMDA Policy Statement for the Utility of Autologous or Family Cord Blood Unit Storage (This policy statement has been approved and adopted by the WMDA board on the 25 th of May 2006) The Cord Blood Registries
Current Issues in Stem Cell Technologies. Lance D. Trainor, MD OneBlood, Inc.
Current Issues in Stem Cell Technologies Lance D. Trainor, MD OneBlood, Inc. Objective: The big picture of stem cell therapy Outline: Relevant definitions History of Stem Cell Therapy Hematopoietic Stem
Roche Position on Human Stem Cells
Roche Position on Human Stem Cells Background Stem cells and treating diseases. Stem cells and their applications offer an enormous potential for the treatment and even the cure of diseases, along with
Stem Cell Quick Guide: Stem Cell Basics
Stem Cell Quick Guide: Stem Cell Basics What is a Stem Cell? Stem cells are the starting point from which the rest of the body grows. The adult human body is made up of hundreds of millions of different
Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.
INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.
PART I. SECTION 1. The legislature finds that an estimated. 128,000,000 Americans suffer from the crippling economic and
HOUSE OF REPRESENTATIVES TWENTY-FOURTH LEGISLATURE, 2007 STATE OF HAWAII A BILL FOR AN ACT RELATING TO MEDICAL RESEARCH. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: PART I SECTION 1. The legislature
Briefing on the second reading of the Human Fertilisation and Embryology Bill, Monday 19 November 2007.
Briefing on the second reading of the Human Fertilisation and Embryology Bill, Monday 19 November 2007. Prepared by the Medical Research Council, Royal Society and Wellcome Trust The Medical Research Council,
NEW ADVANCES IN MYOCARDIAL INFARCTION THERAPY: THE REGENERATION APPROACH
NEW ADVANCES IN MYOCARDIAL INFARCTION THERAPY: THE REGENERATION APPROACH Giovanni Esposito, MD, PhD Dipartimento di Cardiologia, Cardiochirurgia ed Emergenze Cardiovascolari Laboratorio di Emodinamica
Background Information
Background Information 1. What are stem cells? 2. What might stem cell research achieve? 3. Why we need to continue research using embryonic stem cells? 4. Time taken for discoveries 5. Examples of stem
Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen
Version 1 2015 Module guide International Master Program Cardiovascular Science University of Göttingen Part 1 Theoretical modules Synopsis The Master program Cardiovascular Science contains four theoretical
Phone: +44 20 8123 2220 Fax: +44 207 900 3970 office@marketpublishers.com http://marketpublishers.com
Global Stem Cell Umbilical Cord Blood (UCB) Market (Storage Service, Therapeutics, Application, Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012-2020
guides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research
infoaging guides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research WHAT ARE STEM CELLS? Stem cells are cells that, in cell cultures
CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)
CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) March 2014 2014 MVP Health Care, Inc. CHAPTER 9 CHAPTER SPECIFIC CATEGORY CODE BLOCKS I00-I02 Acute rheumatic fever I05-I09 Chronic rheumatic heart
TERUMO Corporation Business Strategy Conference
TERUMO Corporation Business Strategy Conference THERAPEUTIC SYSTEMS & CELL PROCESSING MARK FLOWER GLOBAL MARKETING December 5, 2011 Regenerative Medicine, Cell Therapy, & Cell Processing Regenerative Medicine
STEM CELL FACTS. The ISSCR is an independent, nonproft organization providing a global forum for stem cell research and regenerative medicine.
STEM CELL FACTS The ISSCR is an independent, nonproft organization providing a global forum for stem cell research and regenerative medicine. WHAT ARE STEM CELLS? Stem cells are the foundation cells for
STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA
STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA OVO CLINIC I 8000 BLVD DECARIE, MONTREAL QC H4P 2S4 I 514.798.2000 I OVOCLINIC.COM 2 a therapeutic revolution As the
Human stem cell research: a novel technology that will benefit patients Information and Position Paper
October 2003 Human stem cell research: a novel technology that will benefit patients Information and Position Paper EuropaBio, the European Association for Bio-industries, has 35 corporate members operating
Stem Cell Therapy. THE DARK AND BRIGHT ASPECTS of Stem Cell Therapy
Stem Cell Therapy THE DARK AND BRIGHT ASPECTS of Stem Cell Therapy Stem Cells Our last Weapon? The last weapon in the medical armamentarium? Bye the way.. What IS a last weapon? I don t know about today,
I. REPORT FOCUS A. INTRODUCTION FUNCTIONS OF STEM CELLS STEM CELL APPLICATIONS STEM CELL MILESTONES DEFINITION AND IMPORTANCE STEM CELL DEBATE
I. REPORT FOCUS A. INTRODUCTION FUNCTIONS OF STEM CELLS STEM CELL APPLICATIONS STEM CELL MILESTONES DEFINITION AND IMPORTANCE STEM CELL DEBATE CONCLUSION B. STEM CELLS - THE BEGINNING OF ALL BLOOD CELLS
Adult Cardiac Surgery ICD9 to ICD10 Crosswalks
164.1 Malignant neoplasm of heart C38.0 Malignant neoplasm of heart 164.1 Malignant neoplasm of heart C45.2 Mesothelioma of pericardium 198.89 Secondary malignant neoplasm of other specified sites C79.89
Stem cells possess 2 main characteristics: Sources of pluripotent stem cells: -Long-term self renewal. -The inner cell mass of the blastocyst.
Stem cells possess 2 main characteristics: -Long-term self renewal. - They give rise to all types of differentiate cells. Sources of pluripotent stem cells: -The inner cell mass of the blastocyst. - Fetal
Saving Cord Tissue for Your Family
Saving Cord Tissue for Your Family Dear Future Mom and/or Dad, All of us at CorCell would like to give you a big CONGRATULATIONS on your pregnancy! Now that you are expecting, you have probably heard about
The Therapeutic Potential of Human Umbilical Cord Blood Transplantation for Neonatal Hypoxic-Ischemic Brain Injury and Ischemic Stroke
The Therapeutic Potential of Human Umbilical Cord Blood Transplantation for Neonatal Hypoxic-Ischemic Brain Injury and Ischemic Stroke a,b* b,c a a b b b b a b a b c 430 Wang et al. Acta Med. Okayama Vol.
Stem Cells. Part 1: What is a Stem Cell?
Stem Cells Part 1: What is a Stem Cell? Stem cells differ from other kinds of cells in the body. When a stem cell divides by mitosis, each new cell has the potential to either remain a stem cell or become
Celyad. C-Cure : first-in-class reparative therapy for heart failure treatment. From discovery at Mayo Clinic to European Phase III trial
Celyad C-Cure : first-in-class reparative therapy for heart failure treatment From discovery at Mayo Clinic to European Phase III trial Treating Heart Failure by engaging the heart s reparative mechanisms
15 Stem Cell Research
15 Stem Cell Research t a l k it o v e r 1 c l a s s se s s i o n Overview Students read about current scientific research on and the social controversy over embryonic stem cells. On a KWL literacy strategy
Ischemia and Infarction
Harvard-MIT Division of Health Sciences and Technology HST.035: Principle and Practice of Human Pathology Dr. Badizadegan Ischemia and Infarction HST.035 Spring 2003 In the US: ~50% of deaths are due to
Stem Cell Therapy. Treat your pain, improve your lifestyle and look after your wellbeing. What are stem cells?
(02) 9824 3044 LIVERPOOL NSW 2170 Stem Cell Therapy Treat your pain, improve your lifestyle and look after your wellbeing What are stem cells? Stem cells are cells that can differentiate into other types
BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY
BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY American Osteopathic Association and the American College of Osteopathic Internists Specific Requirements For Osteopathic Subspecialty Training In Cardiology
Global Stem Cell Umbilical Cord Blood
Report Code: DI 14114 Global Stem Cell Umbilical Cord Blood (product Types, Application, Technology, End Users and Geography) Global Share, Size, Industry Analysis, Trends, Opportunities, Growth and Forecast,
your complete stem cell bank
your complete stem cell bank HYDERABAD - 88985 000 888, WARANGAL - 8297 256 777 VISAKHAPATNAM - 7799 990 774 VIJAYAWADA AND GUNTUR - 7799 990 771 NELLORE - 7799 990 772, KADAPA - 8297 256 700 RAJAHMUNDRY
Demystifying Stem Cells. Brent Bost M.D., CPA, MBA, FACOG
Demystifying Stem Cells Brent Bost M.D., CPA, MBA, FACOG Disclaimers Author currently serves on Board of Directors of CordTrack Most applications discussed today are not currently FDA approved and are,
Stem Cells and Inner Ear Cell Regeneration. Stefan Heller Stanford University School of Medicine
Stem Cells and Inner Ear Cell Regeneration Stefan Heller Stanford University School of Medicine Embryonic stem cells Induced pluripotent stem cells Somatic stem cells 50 µm Derived from the inner cell
Should Stem Cells Be Used To Treat Human Diseases?
SAMPLE ESSAY C Should Stem Cells Be Used To Treat Human Diseases? Stem cells can be defined as undifferentiated cells that are generated during the development of the embryo. There are two functions ascribed
Cellular Therapy and Cord Blood Market Report 2013 Page 1. Kathy Gray Worldwide Market Reports & Consulting Coordinator Select Biosciences
Cellular Therapy and Cord Blood Market Report 2013 Kathy Gray Worldwide Market Reports & Consulting Coordinator Select Biosciences k.gray@selectbio.com Select Biosciences Market Reports Website: SelectBiosciences.com/marketreports/
2012 Scientific Sessions of the ACC March 24, 2012. Emerson C Perin, MD, PhD
Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Ischemic Heart Failure: The FOCUS CCTRN Trial
Biobanking Pluripotent Stem Cell Lines: UK and EU regulations Glyn Stacey, UK Stem Cell Bank, NIBSC
Biobanking Pluripotent Stem Cell Lines: UK and EU regulations Glyn Stacey, UK Stem Cell Bank, NIBSC ISCT Conference, New Zealand, April 2013 April 1 st 2013 NIBSC will become part of the Medicines and
Perioperative Cardiac Evaluation
Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project
Umbilical Cord Blood Stem Cells Current Status & Future Potential
Umbilical Cord Blood Stem Cells Current Status & Future Potential Natasha Ali Assistant Professor Haematology Department of Pathology & Laboratory Medicine/Oncology The Aga Khan University Email: natasha.ali@aku.edu
Exchange solutes and water with cells of the body
Chapter 8 Heart and Blood Vessels Three Types of Blood Vessels Transport Blood Arteries Carry blood away from the heart Transport blood under high pressure Capillaries Exchange solutes and water with cells
The Commercialization of Stem Cells ANNA CAULDWELL, PHD ANALYST, CNS, AUTOIMMUNE/INFLAMMATION & OPHTHALMOLOGY
The Commercialization of Stem Cells ANNA CAULDWELL, PHD ANALYST, CNS, AUTOIMMUNE/INFLAMMATION & OPHTHALMOLOGY Recent advances have shown that stem cells can provide truly restorative and diseasemodifying
US Regulations for Import and Export of Cell Therapy Products
US Regulations for Import and Export of Cell Therapy Products Kurt Gunter, MD U Minnesota UCB Transplants (2001-2007)* Total units: 790 Number US banks: 19 Number non-us banks: 12 % units from non-us banks:
CHESHIRE EAST COUNCIL DRIVER MEDICAL
BLOCK LETTERS PLEASE: CHESHIRE EAST COUNCIL DRIVER MEDICAL FULL NAME OF APPLICANT:.. DATE OF BIRTH.... ADDRESS:............. POST CODE... This certificate, which must be completed by a Registered Medical
Stem Cells and Hope for Patients
Stem Cells and Hope for Patients by Maureen Condic, Ph.D. Most Americans know someone afflicted with an incurable medical condition. The possibility of stem cell cures has given hope to many who face such
CARDIAC CARE. Giving you every advantage
CARDIAC CARE Giving you every advantage Getting to the heart of the matter The Cardiovascular Program at Northwest Hospital & Medical Center is dedicated to the management of cardiovascular disease. The
Stem cells and motor neurone disease
Stem cells and motor neurone disease F Stem cell research has fuelled hope of a treatment for a variety of conditions. This information sheet explains what these cells are and includes details of the current
Support structure for genetic material
Support structure for genetic material 1 Making proteins in the RER Making copies of humans 2 Making copies of cells Making copies of genetic material 3 Making copies of genetic material Making copies
The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38
Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac
Unit 1 Higher Human Biology Summary Notes
Unit 1 Higher Human Biology Summary Notes a. Cells tissues organs body systems Division of labour occurs in multicellular organisms (rather than each cell carrying out every function) Most cells become
The therapies are focused in cardiovascular, orthopedics and neurological indications.
1 2 CescaTherapeutics is (to our knowledge) the first company to integrate all of the essential: 1. Cell friendly devices, 2. Proprietary cell formulations, and Strict clinical steps to ensure the autologous
Brochure More information from http://www.researchandmarkets.com/reports/2860999/
Brochure More information from http://www.researchandmarkets.com/reports/2860999/ Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer
Biotechnology. Srivatsan Kidambi, Ph.D.
Stem Stem Cell Cell Engineering-What, Biology and it Application Why, How?? to Biotechnology Srivatsan Kidambi, Ph.D. Assistant Professor Department of Chemical & Biomolecular Engineering University of
Cord Blood Bank Business Plan
Cord Blood Bank Business Plan A sample of how to create a new program Produced by the AABB subsection: Cellular Therapy Business Management with major contributions by Nicole Omer TABLE OF CONTENTS Page
Zutphen, 15 May 2013 Arnoud van Tulder Chief Executive Officer
Zutphen, 15 May 2013 Arnoud van Tulder Chief Executive Officer 1 Non-recurring events 2012 Non-recurring costs in 2012 of 16.2 million: - Non-cash impairment of goodwill and other assets: 15.1 million
Save up to 25% off stem cell banking with Netcells Biosciences
Save up to 25% off stem cell banking with Netcells Biosciences In a unique offering, we have been able to arrange an exclusive offer for medical scheme members with Netcells Biosciences Africa s leading
House Resolution No. 37
california legislature regular session House Resolution No. Introduced by Assembly Member Hill August, House Resolution No. Relative to umbilical cord blood banking. WHEREAS, Since the first umbilical
Magnetic Resonance Quantitative Analysis. MRV MR Flow. Reliable analysis of heart and peripheral arteries in the clinical workflow
Magnetic Resonance Quantitative Analysis MRV MR Flow Reliable analysis of heart and peripheral arteries in the clinical workflow CAAS MRV Functional Workflow Designed for imaging specialists, CAAS MRV
The Cell Therapy Catapult UK Clinical Trials Database
May 2015 The UK Clinical Trials Database covers cell therapy clinical trial activity that the Cell Therapy Catapult believes to be ongoing in the UK as of May 2015. It supersedes the database of April
Patient Handbook on Stem Cell Therapies
Patient Handbook on Stem Cell Therapies Appendix I of the Guidelines for the Clinical Translation of Stem Cells www.isscr.org 2008, International Society for Stem Cell Research 2 Introduction We have all
Stem Cell Research in India: Emerging Scenario and Policy Concerns
RIS Research and Information System for Developing Countries www.ris.org.in/abdr.html Asian Biotechnology and Development Review Vol. 8 No. 3, pp 43-53 2006, RIS. All rights reserved 43 Printed in India
Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona
Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona Areas to be covered Historical, current, and future treatments for various cardiovascular disease: Atherosclerosis (Coronary
tem ells /background /information Stem cell research Copyright 2007 MRC Centre for Regenerative Medicine, Institute for Stem Cell Research
tem ells /background /information Stem cell research Copyright 2007 MRC Centre for Regenerative Medicine, Institute for Stem Cell Research /02 /information Table of contents Page 01. What are stem cells?
6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology
Objectives Acute Coronary Syndromes Epidemiology and Health Care Impact Pathophysiology Unstable Angina NSTEMI STEMI Clinical Clues Pre-hospital Spokane County EMS Epidemiology About 600,000 people die
THE PROMISE OF STEM CELL RESEARCH
THE PROMISE OF STEM CELL RESEARCH MALIGNANT OSTEOPETROSIS AUTOSOMAL RECESSIVE DENSE SCLEROTIC SKELETON HEMATOLOGIC ABNORMALITIES NEUROLOGIC ABNOMALITIES DEATH IN INFANCY OR EARLY CHILDHOOD SUCCESS RATE
Saving your baby s s cord blood: Is this good insurance?
Saving your baby s s cord blood: Is this good insurance? 32 th SEMINAR ON PERINATAL MEDICINE CONTROVERSIES IN PERINATAL MEDICINE: EVIDENCE FOR CURRENT PRACTICE Sante Fe, New Mexico Mervin C. Yoder, MD
How To Understand What You Know
Heart Disorders Glossary ABG (Arterial Blood Gas) Test: A test that measures how much oxygen and carbon dioxide are in the blood. Anemia: A condition in which there are low levels of red blood cells in
Global Glossary of Terms and Definitions on Donation and Transplantation
Global Glossary of Terms and Definitions on Donation and Transplantation Geneva, November 2009 1 2 Global Glossary of terms and definitions on donation and transplantation The lack of a globally recognized
Rudolf de Boer. Paula Da Costa Martins. Ralph van Oort. Kevin Vernooij. Daniël Pijnappels. Lynda Juffermans. Toon van Veen. Peter van der Meer
Paula Da Costa Martins Ralph van Oort Lynda Juffermans Kevin Vernooij Daniël Pijnappels Toon van Veen Rudolf de Boer Linda van Laake Kim Van der Heiden Matthijs Boekholdt Peter van der Meer Blanche Schroen
Progenitor Cell Therapy for the Treatment of Damaged Myocardium due to Ischemia
Progenitor Cell Therapy for the Treatment of Damaged Myocardium due to Ischemia Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana,
Stem Cells: Scientific Progress and Future Research Directions
2001 Terese Winslow Stem Cells: Scientific Progress and Future Research Directions STEM CELLS: SCIENTIFIC PROGRESS AND FUTURE RESEARCH DIRECTIONS June 2001 This page intentionally left blank TABLE OF CONTENTS
Stem cells and cellular therapies: from research to clinic. ns,, PhD Faculty of Biology University of Latvia
Stem cells and cellular therapies: from research to clinic Janis Ancans ns,, PhD Faculty of Biology University of Latvia Our cells Human body originates from one stem cell Conventional drugs Long history
Hematopoiesis i starts from. HPC differentiates t to sequentially more mature. HPC circulate in very low
Upstate Cord Blood Bank Hematopoietic Progenitor Cells Hematopoiesis i starts from self renewing HPC HPC differentiates t to sequentially more mature blood cells HPC circulate in very low numbers in adults
Mediafin Investor Night: TiGenix NV. 23 September 2015
Mediafin Investor Night: TiGenix NV 23 September 2015 Forward-looking Statements This document does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer
International NetCord Foundation Executive Committee Conference Call Minutes May 23, 2007
International NetCord Foundation Executive Committee Conference Call Minutes Committee Members: Board Members: Staff: President Joan Garcia and Drs. Yves Beguin and Elizabeth Shpall Drs. Cristina Navarrete
Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease
Heart Failure Center Hadassah University Hospital Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Israel Gotsman MD The Heart Failure Center, Heart Institute Hadassah University
National Medical Policy
National Medical Policy Subject: Policy Number: Stem Cell Therapy for Treatment of Heart Failure and Acute Myocardial Infarction NMP316 Effective Date*: January 2007 Updated: May 2016 This National Medical
1p36 and the Heart. John Lynn Jefferies, MD, MPH, FACC, FAHA
1p36 and the Heart John Lynn Jefferies, MD, MPH, FACC, FAHA Director, Advanced Heart Failure and Cardiomyopathy Services Associate Professor, Pediatric Cardiology and Adult Cardiovascular Diseases Associate
Differentiation = Making specialized cells
Differentiation = Making specialized cells What is a stem cell? Screws: JM www.logodesignweb.com/stockphoto Differentiation = Making specialized cells What is a stem cell? What the photo shows A lump of
Stem cells for brain cures
13-14/11/2006, Istituto Superiore di Sanità Rome, Italy Frontiers in Imaging Science: High Performance Nuclear Medicine Imagers for Vascular Disease Imaging (Brain and Heart) Stem cells for brain cures
UC Davis Institute for Regenerative Cures A facility supported by the California Institute for Regenerative Medicine
UC Davis Institute for Regenerative Cures A facility supported by the California Institute for Regenerative Medicine Naming Opportunities Opportunity No. Description/Features Gift Amount Institute for
CARDIA 288 MONTH FOLLOW-UP SUPPLEMENTAL FORM (FORM B) HOSPITALIZATION CASE #: INTERVIEWER ID FY288BIVID2. Page 1 of 6 FY288BH4CN
HOSPITALIZATION CASE #: 2 8 8 0 H FY288BH4CN Has the participant indicated any of the following reasons for being admitted overnight for this case? 1. Suspected or confirmed problems with the heart, circulation,
Please visit this site for the current GESCR procedures info: http://www.research.ucsf.edu/chr/stemcell/scprocedures.asp
GESCR PROCEDURES: REVIEW PROCESS AND LEVELS OF REVIEW Office of Origin: Human Research Protection Program Effective Date: January 2012 I. Introduction The Human Gamete, Embryo and Stem Cell Research (GESCR)
Top Ten Things to Know About Stem Cell Treatments
Top Ten Things to Know About Stem Cell Treatments Many clinics that are offering stem cell treatments make claims about what stem cells can and cannot do that are not supported by our understanding of
CELL THERAPY MARKETS
TriMark Publications July 2007 Volume: TMRCTHER07-0701 CELL THERAPY MARKETS (SAMPLE COPY, NOT FOR RESALE) Trends, Industry Participants, Product Overviews and Market Drivers TABLE OF CONTENTS 1. Overview
UNIVERSITA' DEGLI STUDI DI ROMA TOR VERGATA
SYSTEMATIC PATHOLOGY I IIIYear Scientific Field DISCIPLINE TUTOR Systematic Pathology I MED/21 MED/10 Thoracic Surgery Respiratory Diseases Tommaso Claudio Mineo Paola Rogliani MED/10 Respiratory Diseases
Annual General Meeting of Shareholders 19 May 2010
Annual General Meeting of Shareholders 19 May 2010 2009 results 2010 Q1 highlights Arnoud van Tulder CEO 19 May 2010 www.cryo-savegroup.com Highlights 2009 Strong financial results and cash position year
Technology Analysis and Market Outlook
Investing in Regenerative Medicine: Technology Analysis and Market Outlook 2014 Report #1 ISBN # 978-0-9912902-1-5 May 2014 Table of Contents Glossary...2 Introduction... 4 Regenerative Medicine Landscape...